Abstract
We have previously presented results suggesting that HLA antigen status could predict the response of cancer to therapy, and have proposed that rational individualized therapy for cancer patients might possibly be designed by evaluating HLA antigens. In this study, we classified gastric cancer patients into four groups using quantification method III and then developed a simple method of classifying patients to HLA antigen status for easy clinical application.
